FORMATION OF INACTIVE CYTOCHROME-P-450 FE(II)-METABOLITE COMPLEXES WITH SEVERAL ERYTHROMYCIN DERIVATIVES BUT NOT WITH JOSAMYCIN AND MIDECAMYCIN IN RATS

被引：92

作者：

LARREY, D ^{[1
]}

TINEL, M ^{[1
]}

PESSAYRE, D ^{[1
]}

机构：

[1] HOP BEAUJON,UNITE RECH PHYSIOPATHOL HEPAT,INSERM U24,F-92118 CLICHY,FRANCE

来源：

关键词：

D O I：

10.1016/0006-2952(83)90470-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1487 / 1493

页数：7

共 27 条

[1] POSSIBLE WARFARIN-ERYTHROMYCIN INTERACTION [J].

BARTLE, WR .

[2]

BRAZEAU P, 1970, PHARMACOL BASIS THER, P893

[3]

BRAZIER JL, 1980, THERAPIE, V35, P545

[4]

CUMMINS LH, 1977, PEDIATRICS, V59, P144

[5]

DANAN G, 1981, J PHARMACOL EXP THER, V218, P509

[6]

DRAVET C, 1977, LANCET, V1, P810

FRANKLIN, MR .

PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS, 1977, 2 (01) :227-245

FRANKLIN, MR .

[9]

GROLLEAU JY, 1981, THERAPIE, V36, P319

[10]

Hayton A C, 1969, N Z Med J, V69, P42